Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00RCI
|
||||
Former ID |
DNAP001275
|
||||
Drug Name |
Teduglutide
|
||||
Synonyms |
Gattex (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
NPS
|
||||
Structure |
Download2D MOL |
||||
Formula |
C164H252N44O55S
|
||||
CAS Number |
CAS 197922-42-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:72305
|
||||
SuperDrug ATC ID |
A16AX08
|
||||
Target and Pathway | |||||
Target(s) | Glucagon-like peptide 2 receptor | Target Info | Modulator | [551871] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References | |||||
Ref 524696 | ClinicalTrials.gov (NCT02099084) Short Bowel Syndrome and Teduglutide VS Placebo. U.S. National Institutes of Health. | ||||
Ref 542060 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7049). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.